Search Results

Showing results 21-31 of 31 for 'Blood'

  • yaniv-karina-tn
    Dr. Karina Yaniv to be honored with LE&RN's 2016 Wendy Chaite Leadership Award

    The Lymphatic Education & Research Network has announced that it is awarding its prestigious Wendy Chaite Leadership Award to Weizmann's Dr. Karina Yaniv. With funding support from the organization, Dr. Yaniv recently showed – for the first time – how the lymphatic system develops. The award will be presented on March 23 by actor Kathy Bates.

  • the-transformation-tn
    The Transformation

    Writing in The New Yorker, Dr. Jerome Groopman examines whether controlling cancer is a more viable option than trying to destroy it. A new treatment for the often-fatal acute myelogenous leukemia (AML) aims to do just that by forcing immature cells to grow up, rather than turn into leukemia cells – a breakthrough that builds on the work of Weizmann's Prof. Leo Sachs.

  • choroid-plexus-tn
    We Can Restore Cognition by Manipulating Where the Body Meets the Mind

    Prof. Michal Schwartz, world-renowned neuroscientist, along with Weizmann Institute PhD student Aleksandra Deczkowska and postdoc Kuti Baruch write in Science 2.0 about their study of the aging brain, and discovering that the choroid plexus – a unique interface between the brain and the body – is involved in the aging process.

  • sharing-mothers-stress-tn
    Sharing Mother's Stress in the Womb Leaves Children Prone to Depression

    Weizmann's Prof. Alon Chen and colleagues in the U.K. have discovered a key part of the placenta that protects the fetus from the mother's high stress hormones; however, when this element doesn't work, the child is more prone to anxiety and depression. As The Telegraph reports, a diagnostic test could identify at-risk children.

  • Top 10 Israeli Medical Advances to Watch in 2014

    Israel21c names Prof. Michal Schwartz's early-diagnosis blood test for Alzheimer's disease and ALS one of the top 10 Israeli medical advances to watch in 2014. The company NeuroQuest conducted trials in Israel that showed the test has an astonishing accuracy rate of 87%, enabling much earlier intervention for these neurodegenerative diseases.

  • yair-reisner-cell-source-tn
    Cell Source's Megadose Drug Combination Treats First Patient

    Cell Source, the biotech firm that is developing Prof. Yair Reisner's ""megadose"" stem cell therapy, announced that the first cancer patient appears to have been successfully treated. The treatment allows bone marrow transplants between mismatched donors and patients, reducing levels of rejection and increasing rates of success and survival.

  • Emily-Whitehead-thumb
    Therapy Programs Patients’ Own Cells to Fight Cancer

    A decades-old ""audacious idea"" by Weizmann's Prof. Zelig Eshhar helped create a cancer treatment that has now led to full remissions in almost 20 adult and pediatric blood-cancer patients. Considered the future of cancer research by many, the therapy programs the patient's own immune cells to recognize and attack cancer.

  • shachar-idit_2-tn.jpg
    Target: Blood Cancers

    Read about Prof. Idit Shachar's search for an improved treatment for chronic lymphocytic leukemia and other blood cancers. She and her team discovered a blocking antibody that showed great promise in killing cancer cells in a clinical trial. Prof. Shachar also addresses the challenges of being a woman (and mom) in science. This is WeizmannViews Issue No. 45.

  • shutterstock_624262319_blood vessels.jpg
    First Blood Cells

    One of the first organ systems to form and function in the embryo is the cardiovascular system: in fact, this developmental process starts so early that scientists still have many unresolved questions on the origin of the primitive heart and blood vessels. How do the first cells – the progenitors – that are destined to become part of this system participate in shaping the developed cardiovascular system? Dr. Lyad Zamir, a former PhD student in the lab of Prof. Eldad Tzahor in the Weizmann Institute of Science’s Department of Molecular Cell Biology, developed a method to image the earliest cardiovascular progenitors and track them and their descendants through the developing embryo in real time. His movies took place in fertilized chicken eggs, in which a complex network of blood vessels forms within the yolk sac to nourish the embryo. The findings of this research were recently published in eLife.

  • 393777.jpg
    Can the Organ of Life Save Lives?

    As <em>The Jerusalem Post</em> reports, Pluristem uses technology developed by Weizmann and the Technion to develop cell therapies for conditions such as inflammation, muscle injuries, blood disorders – even for “victims of radioactive catastrophes.”